Pay in 4 interest-free payments of $6.03 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Composition GHK-Cu: 50 mg BPC-157: 10 mg TB-500 (Thymosin Beta 4): 10 mg Appearance: lyophilized powder in a sealed research vial Research Focus (non-clinical) Combined evaluation of copper peptide, BPC-157, and TB-500 in in-vitro or ex-vivo assay systems Assay development, including chromatographic separation of three co-formulated peptides Stability characterization of a three-analyte lyophilized blend under laboratory storage conditions Method documentation for HPLC/LC-MS identity and purity assessments Documentation Analysis Report Important Notice For research use only Not for human consumption Not intended to diagnose, treat, cure, or prevent any disease Quality & Manufacturing Lot-specific COA Lyophilized for transit stability
Do not use in children unless specifically prescribed by a qualified healthcare provider
Before selecting a supplier, brands should request: COA Assay method Heavy metal testing Microbial testing Residual solvent testing, if applicable Country of origin Allergen statement GMO status Vegan/vegetarian statement Halal or kosher status, if needed 3
When you receive GLP-1 therapy, the medication helps you feel fuller after meals, naturally reducing your calorie intake
Abstract Purpose of Review Hypertension is the leading modifiable risk factor for cardiovascular disease
US$ 23.74
US$ 22.95
US$ 26.50
US$ 28.66
US$ 24.94
